Get the Stockscreener App
0.7485
8.16%
-0.0665
Pre-market:
.75
0.0015
+0.20%
AEON Biopharma Inc. stock is traded at $0.7485, with a volume of 145.77K.
It is down -8.16% in the last 24 hours and down -21.14% over the past month.
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
See More
Previous Close:
$0.815
Open:
$0.81
24h Volume:
145.77K
Relative Volume:
0.62
Market Cap:
$8.86M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-10.47%
1M Performance:
-21.14%
6M Performance:
+14.36%
1Y Performance:
-98.45%
1-Day Range:
$0.74
$0.81
1-Week Range:
$0.74
$0.874
52-Week Range:
$0.375
$64.80
AEON Biopharma Inc. Stock (AEON) Company Profile
Name
AEON Biopharma Inc.
Sector
Industry
Phone
(949) 354-6499
Address
5 Park Plaza, Suite 1750, Irvine
Compare AEON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.7485 | 9.65M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-23 | Initiated | H.C. Wainwright | Buy |
AEON Biopharma Inc. Stock (AEON) Latest News
How AEON Biopharma Inc. Class stock performs in volatility spikesQuarterly Market Review & Fast Gain Stock Trading Tips - Newser
Can AEON Biopharma Inc. Class stock retain market dominanceJuly 2025 Summary & Trade Opportunity Analysis Reports - Newser
AEON Biopharma Releases New Corporate Presentation - TipRanks
AEON Biopharma : Corporate Presentation - marketscreener.com
AEON Biopharma (NYSE: AEON) releases new investor Corporate Presentation - Stock Titan
AEON Biopharma, Inc. Releases Corporate Presentation on Biosimilar Development - TradingView
Migraine Clinical Trial Pipeline Expands as 30+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight - GlobeNewswire Inc.
Aeon Biopharma Reports Positive Data and Strategic Moves - MSN
Aeon Secures Funding As FDA Sets New Date For Botox Biosimilar Review - Citeline News & Insights
Check out these key findings about AEON Biopharma Inc (AEON) - Setenews
How AEON Biopharma Inc. Class stock valuation compares with sector2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
AEON Biopharma (NASDAQ:AEON) Upgraded at Zacks Research - Defense World
Aeon Biopharma announces first closing of PIPE investment and provides update on FDA Type 2A meeting scheduling - MarketScreener
Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling - TradingView
AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling - The Manila Times
AEON Biopharma Inc: FDA Bpd Type 2a Meeting N - 富途牛牛
Can AEON Biopharma Inc. Class stock survive global slowdownWeekly Profit Analysis & Expert Curated Trade Setup Alerts - newser.com
Will AEON Biopharma Inc. Class stock beat international competitionWeekly Earnings Recap & Capital Protection Trading Alerts - newser.com
Applying big data sentiment scoring on AEON Biopharma Inc.July 2025 PostEarnings & Verified Short-Term Plans - newser.com
Why AEON Biopharma Inc. Class stock signals breakout potentialPortfolio Gains Summary & Smart Allocation Stock Reports - newser.com
Will AEON Biopharma Inc. Class stock announce special dividendBreakout Watch & Verified High Yield Trade Plans - newser.com
Will AEON Biopharma Inc. Class stock return to pre crash levelsTrade Risk Report & Free Expert Approved Momentum Trade Ideas - newser.com
What earnings margins imply for AEON Biopharma Inc. Class stockMarket Performance Summary & AI Enhanced Trade Execution Alerts - newser.com
Is AEON Biopharma Inc. Class stock among top earnings plays2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com
How forex fluctuations impact AEON Biopharma Inc. Class stockJuly 2025 Volume & Weekly Market Pulse Alerts - newser.com
Will AEON Biopharma Inc. price bounce be sustainableJuly 2025 Technicals & Expert Curated Trade Setup Alerts - newser.com
Can AEON Biopharma Inc. stock resist market sell offs - newser.com
Published on: 2025-11-19 04:38:24 - newser.com
How big funds are accumulating AEON Biopharma Inc. Class stock2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Relative strength of AEON Biopharma Inc. in sector analysisTrade Entry Report & Consistent Profit Alerts - newser.com
Is AEON Biopharma Inc. stock attractive for ETFsQuarterly Profit Summary & Verified Entry Point Signals - newser.com
AEON Biopharma Inc. Stock (AEON) Financials Data
There is no financial data for AEON Biopharma Inc. (AEON). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Cap:
|
Volume (24h):